KDM1A and breast carcinoma: To best of our knowledge this is the first study demonstrating LSD1 inhibition in breast cancer resulting in depletion of CTC with stemness features and a phenotypic switch from mesenchymal to more epithelial CTC in patients with metastatic breast cancer.